Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Nucleolar and nuclear aberrations in human lox tumor cells following treatment with p120 antisense oligonucleotide ISIS-3466

L Perlaky, K Smetana, RK Busch, Y Saijo, H Busch

. 1993 ; 74 (1-2) : 125-135.

Jazyk angličtina Země Irsko

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13027557

Grantová podpora
IZ28 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Část
Zdroj

E-zdroje Online Plný text

NLK ScienceDirect (archiv) od 1993-01-01 do 2009-12-31

Previous reports from this laboratory have shown marked cytocidal effects of the ISIS-3466 antisense phosphorothioate oligodeoxynucleotide to the human nucleolar protein p120 on human cancer cell lines in vitro and inhibition of tumor growth in vivo in an i.p/i.p. LOX cell model (L. Perlaky et al. Anti-Cancer Drug Design 8:3-14, 1993). In this study, light and fluorescence microscopy showed that the number of LOX cells in mitosis decreased by 50% after incubation for 4 h in 0.2-0.4 microM antisense oligonucleotide; a 70% reduction in cell number was found from 8-72 h post-treatment. In addition, marked unravelling of nucleolar structures and chromatin fragmentation was found after a 4-h incubation. The nucleolar unravelling occurred in varying degrees ranging from partial unfolding to almost complete separation of the strands of nucleolar residues. Twenty four hours post-treatment, immunofluorescence staining with the anti-p120 monoclonal antibody showed reduced nucleolar protein p120 and translocation of the p120 protein from the nucleoli to the nucleoplasm. Analysis of the mechanisms of the nucleolar unravelling and inhibition of mitosis will provide further understanding of the cytocidal effects of the ISIS-3466 antisense oligonucleotide.

000      
00000naa a2200000 a 4500
001      
bmc13027557
003      
CZ-PrNML
005      
20130828155123.0
007      
ta
008      
130823s1993 ie ad f 000 0|eng||
009      
AR
035    __
$a (PubMed)8287366
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Perlaky, Laszlo $u Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030.
245    10
$a Nucleolar and nuclear aberrations in human lox tumor cells following treatment with p120 antisense oligonucleotide ISIS-3466 / $c L Perlaky, K Smetana, RK Busch, Y Saijo, H Busch
520    9_
$a Previous reports from this laboratory have shown marked cytocidal effects of the ISIS-3466 antisense phosphorothioate oligodeoxynucleotide to the human nucleolar protein p120 on human cancer cell lines in vitro and inhibition of tumor growth in vivo in an i.p/i.p. LOX cell model (L. Perlaky et al. Anti-Cancer Drug Design 8:3-14, 1993). In this study, light and fluorescence microscopy showed that the number of LOX cells in mitosis decreased by 50% after incubation for 4 h in 0.2-0.4 microM antisense oligonucleotide; a 70% reduction in cell number was found from 8-72 h post-treatment. In addition, marked unravelling of nucleolar structures and chromatin fragmentation was found after a 4-h incubation. The nucleolar unravelling occurred in varying degrees ranging from partial unfolding to almost complete separation of the strands of nucleolar residues. Twenty four hours post-treatment, immunofluorescence staining with the anti-p120 monoclonal antibody showed reduced nucleolar protein p120 and translocation of the p120 protein from the nucleoli to the nucleoplasm. Analysis of the mechanisms of the nucleolar unravelling and inhibition of mitosis will provide further understanding of the cytocidal effects of the ISIS-3466 antisense oligonucleotide.
590    __
$a bohemika - dle Pubmed
650    12
$a antigeny nádorové $x účinky léků $7 D000951
650    02
$a sekvence nukleotidů $7 D001483
650    12
$a buněčné jadérko $x účinky léků $7 D002466
650    02
$a buněčné jádro $x účinky léků $7 D002467
650    02
$a chromatin $x účinky léků $7 D002843
650    02
$a lidé $7 D006801
650    12
$a amelanotický melanom $x genetika $x chemie $x patologie $7 D018328
650    02
$a fluorescenční mikroskopie $7 D008856
650    02
$a mitóza $x účinky léků $7 D008938
650    02
$a molekulární sekvence - údaje $7 D008969
650    12
$a jaderné proteiny $x účinky léků $7 D009687
650    12
$a antisense oligodeoxyribonukleotidy $7 D020319
650    02
$a antisense oligonukleotidy $x farmakologie $x genetika $7 D016376
650    02
$a thionukleotidy $x farmakologie $x genetika $7 D013873
650    02
$a nádorové buňky kultivované $x účinky léků $7 D014407
650    02
$a tRNA Methyltransferases
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Smetana, Karel, $d 1930- $7 nlk19990073860 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Busch, Rose K. $u Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030.
700    1_
$a Saijo, Yasuo $u Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030.
700    1_
$a Busch, Harris $u Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030.
773    0_
$t Cancer Letters $x 0304-3835 $g Roč. 74, č. 1-2 (1993), s. 125-135 $p Cancer Lett $w MED00001044
910    __
$a ABA008 $y 3 $z 0
990    __
$a 20130823103031 $b ABA008
991    __
$a 20130828155604 $b ABA008
999    __
$a ok $b bmc $g 991520 $s 825985
BAS    __
$a 3
BMC    __
$x MED00001044 $i 0304-3835 $a 1993 $b 74 $c 1-2 $d 125-135 $m Cancer letters $n Cancer Lett
GRA    __
$a IZ28 $p MZ0
LZP    __
$a NLK 2013-08/lpbo

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...